Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02321592
Brief Title: GHSG-AFM13 An Open-label, Multicenter Phase II Trial With AFM13 in Patients With Relapsed or Refractory Hodgkin Lymphoma (GHSG-AFM13)

First Submitted : December 17, 2014
First Submitted that Met QC Criteria : December 19, 2014
First Posted : December 22, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : November 3, 2017
Last Update Posted : November 6, 2017